Anti-malaria vaccine developed in Japan

The following is an edited excerpt.

A team of Japanese researchers say they have developed a vaccine that cuts the risk of malaria developing in humans by more than two-thirds.

The disease kills around 650,000 people each year, mostly African children under five, according to the UN’s World Health Organisation (WHO).

“The vaccine’s effect is greater than those hitherto reported of any other antimalaria vaccines,” a statement issued this week said.

Read the full story here: New Japan malaria vaccine cuts infections ‘by 72%’

A team of Japanese researchers say they have developed a vaccine that cuts the risk of malaria developing in humans by more than two-thirds.

The disease, which is carried by parasite-bearing mosquitoes, kills around 650,000 people each year, mostly African children under five, according to the UN’s World Health Organisation (WHO).

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend